Clinical Trial Update: A Kidney Transplant Study to Look at the Effects of Taking Fixed Doses of CellCept Versus Taking Doses of CellCept Based on the Concentration of CellCept in the Blood When Taking Full or Reduced Dose Calcineurin Inhibitors [Phase 4]

View source ↗

Summary

Phase 4 kidney transplant study comparing fixed-dose versus concentration-based dosing of mycophenolate mofetil (CellCept) in patients receiving calcineurin inh…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Delayed Graft Function
• Kidney Transplantation

Drugs mentioned

• CELLCEPT (mycophenolate mofetil hydrochloride)

Snippet

Sponsor: Mayo Clinic | Conditions: Kidney Transplantation, Delayed Graft Function | Phase 4 | Status: TERMINATED